Solomayer EF - Search Results

1

Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.

Fehm T, Becker S, Becker-Pergola G, Sotlar K, Gebauer G, Dürr-Störzer S, Neubauer H, Wallwiener D, Solomayer EF. Fehm T, et al. Among authors: solomayer ef. Breast Cancer Res. 2006;8(5):R60. doi: 10.1186/bcr1611. Breast Cancer Res. 2006. PMID: 17062129 Free PMC article.

2

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G. Diel IJ, et al. Among authors: solomayer ef. J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8. doi: 10.1093/jnci/88.22.1652. J Natl Cancer Inst. 1996. PMID: 8931609

3

Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.

Solomayer EF, Diel IJ, Wallwiener D, Bode S, Meyberg G, Sillem M, Gollan C, Kramer MD, Krainick U, Bastert G. Solomayer EF, et al. Br J Cancer. 1997;76(6):812-8. doi: 10.1038/bjc.1997.467. Br J Cancer. 1997. PMID: 9310251 Free PMC article.

4

Results of iliac crest biopsies taken from 1465 patients with primary breast cancer.

Solomayer EF, Diel IJ, Krempien B, Meyberg GC, Gollan C, Krainick U, Wallwiener D, Bastert G. Solomayer EF, et al. J Cancer Res Clin Oncol. 1998 Jan;124(1):44-8. doi: 10.1007/s004320050132. J Cancer Res Clin Oncol. 1998. PMID: 9498834 Clinical Trial.

5

Reduction in new metastases in breast cancer with adjuvant clodronate treatment.

Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M, Bastert G. Diel IJ, et al. Among authors: solomayer ef. N Engl J Med. 1998 Aug 6;339(6):357-63. doi: 10.1056/NEJM199808063390601. N Engl J Med. 1998. PMID: 9691101 Free article. Clinical Trial.

6

Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.

Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bode S, Wallwiener D, Bastert G. Solomayer EF, et al. Breast Cancer Res Treat. 1998 May;49(2):145-54. doi: 10.1023/a:1005965927185. Breast Cancer Res Treat. 1998. PMID: 9696397

7

Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.

Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan C, Pecherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G. Diel IJ, et al. Among authors: solomayer ef. Clin Cancer Res. 1999 Dec;5(12):3914-9. Clin Cancer Res. 1999. PMID: 10632320

8

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.

Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G. Solomayer EF, et al. Breast Cancer Res Treat. 2000 Feb;59(3):271-8. doi: 10.1023/a:1006308619659. Breast Cancer Res Treat. 2000. PMID: 10832597

9

Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.

Solomayer EF, Diel IJ, Salanti G, Hahn M, Gollan C, Schütz F, Bastert G. Solomayer EF, et al. Clin Cancer Res. 2001 Dec;7(12):4102-8. Clin Cancer Res. 2001. PMID: 11751508

10

Treatment of metastatic bone disease in breast cancer: bisphosphonates.

Diel IJ, Solomayer EF, Bastert G. Diel IJ, et al. Among authors: solomayer ef. Clin Breast Cancer. 2000 Apr;1(1):43-51. doi: 10.3816/CBC.2000.n.003. Clin Breast Cancer. 2000. PMID: 11899389 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters